Steve Scala

Stock Analyst at TD Cowen

(2.78)
# 1,739
Out of 4,853 analysts
31
Total ratings
69.23%
Success rate
12.68%
Average return

Stocks Rated by Steve Scala

AbbVie
Oct 7, 2024
Maintains: Buy
Price Target: $195$225
Current: $187.47
Upside: +20.02%
Bristol-Myers Squibb Company
Oct 7, 2024
Maintains: Hold
Price Target: $53$59
Current: $47.84
Upside: +23.33%
AstraZeneca
Aug 12, 2024
Maintains: Buy
Price Target: $90$95
Current: $72.35
Upside: +31.31%
Merck & Co.
Jan 4, 2024
Upgrades: Outperform
Price Target: $125$135
Current: $77.62
Upside: +73.92%
Pfizer
Jan 4, 2024
Downgrades: Market Perform
Price Target: $32
Current: $23.12
Upside: +38.41%
Eli Lilly and Company
May 23, 2023
Maintains: Outperform
Price Target: $430$500
Current: $765.68
Upside: -34.70%
Novartis AG
Feb 1, 2021
Downgrades: Market Perform
Price Target: $110$105
Current: $117.79
Upside: -10.86%
Royalty Pharma
Jul 13, 2020
Initiates: Outperform
Price Target: $55
Current: $33.75
Upside: +62.96%